Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis

Background: Systemic reactions and anaphylaxis due to Hymenoptera venoms occur in up to 7.5% of the European population. Fatal sting reactions are very rare. Serum tryptase levels should be measured in all patients with a history of severe reactions in order to detect mastocytosis and to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gülsen, Askin, Ruëff, Franziska, Jappe, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962470/
https://www.ncbi.nlm.nih.gov/pubmed/33733040
http://dx.doi.org/10.5414/ALX02196E

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962470/
https://www.ncbi.nlm.nih.gov/pubmed/33733040
http://dx.doi.org/10.5414/ALX02196E

Ejemplares similares